Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, et al. Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [(18)F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 t Lancet Oncol 2024 Aug 9:S1470-2045(24)00320.
PMID: 39134086